Eli Lilly's drive to provide as many treatment options as possible for its obesity drug Zepbound has continued with the launch of new high-dose vials.

Donald Trump Reporting and commentary on the forty-fifth and forty-seventh President.

Real-time Price Updates for Novo Nordisk A/S ADR (NVO-N), along with buy or sell indicators, analysis, charts, historical performance, news and more ...